Essential Acute Stroke Care in Low Resource Settings: a Pilot studY
Launched by THE GEORGE INSTITUTE · Nov 6, 2019
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Essential Acute Stroke Care in Low Resource Settings," aims to explore how effective basic care for stroke patients can be in places where medical resources are limited. The study will look at patients who have experienced a stroke—either from a blockage in the blood vessels (ischemic) or bleeding (hemorrhagic)—within 72 hours of their symptoms starting. By assessing this care approach, the researchers hope to find out if it can be successfully implemented in these resource-limited environments.
To be eligible for the trial, participants need to be adults aged 18 or older and have a confirmed diagnosis of an acute stroke. They must also be able to provide written consent to join the study. However, individuals who have recently undergone specific emergency treatments for their stroke, those needing intensive care, or those who have had certain types of brain bleeding will not be able to participate. If you join the study, you can expect to receive essential care tailored for acute strokes in a supportive environment. It's important to note that the trial is not yet recruiting participants, so there will be no immediate involvement at this time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults (age ≥18 years)
- • A clinical or imaging-based diagnosis of acute stroke (ischemic or haemorrhagic) within 72 hours of stroke symptom onset
- • Provision of written informed consent
- • Subjects in observational, natural history and/or epidemiological studies not involving an intervention are eligible.
- Exclusion Criteria:
- • Patients who have undergone intravenous thrombolysis or mechanical thrombectomy
- • Patients who are planned for transfer to the intensive care unit
- • Subarachnoid haemorrhage
- • Participation in an interventional medical investigation or clinical trial currently or within the past 3 months.
About The George Institute
The George Institute for Global Health is a leading research organization dedicated to improving health outcomes through innovative clinical trials and groundbreaking research. Based in Australia, the institute focuses on addressing major health challenges, particularly in the areas of chronic diseases, cardiovascular health, and health equity. With a commitment to translating scientific discoveries into real-world applications, The George Institute collaborates with global partners to advance knowledge and implement effective health interventions. Its multidisciplinary team of researchers employs rigorous methodologies to ensure high-quality evidence that informs policy and practice, ultimately striving to enhance public health on a global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kano, Kano State, Nigeria
Lokoja, Kogi State, Nigeria
Piura, , Peru
Piura, , Peru
Patients applied
Trial Officials
Carlos Abanto, Dr
Principal Investigator
National Institute of Neurological Sciences, Lima, Peru
Kolawawole Wahab, Professor
Principal Investigator
University of Ilorin & University of Ilorin Teaching Hospital Ilorin, Nigeria
Hasan Farhan, Professor
Principal Investigator
President of Iraqi Scientific Council of Cardiology,Iraq
Yi Sui, Dr
Principal Investigator
Shenyang First People's Hospital Hospital Affiliated Brain Hospital
Saima Hilal, A/Professor
Principal Investigator
National University of Singapore
Lily Song, Dr
Principal Investigator
The George Institute of Global Health, China
Craig Anderson, Professor
Principal Investigator
Executive Director The George Institute for Global Health - China
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials